Clinical Trial

Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia

Name: Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia — clinical trial record (NCT07572084)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aimed to explore the efficacy and safety of romiplostim N01 in the treatment of chemoradiotherapy-induced aplastic anemia (AA)

Trial Details

NCT Number	NCT07572084
Lead Sponsor	Peking Union Medical College Hospital
Conditions	Aplastic Anemia
Enrollment	43 participants
Start Date	2026-04
Primary Completion	2028-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-07